09.06.2013 Views

9. Treatment of Amatoxin Poisoning-20 year retrospective analysis

9. Treatment of Amatoxin Poisoning-20 year retrospective analysis

9. Treatment of Amatoxin Poisoning-20 year retrospective analysis

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

730<br />

prevented both the rise <strong>of</strong> the liver enzymes and the fall<br />

<strong>of</strong> clotting factors in the blood. [276]<br />

Benzylpenicillin perfusions <strong>of</strong> isolated rat liver<br />

showed a strong inhibition <strong>of</strong> a-Ama toxicity. [277]<br />

Although most b-lactam antibiotics utilize a common<br />

carrier system for uptake into isolated hepatocytes, [278]<br />

kinetic studies <strong>of</strong> a-Ama absorption in hepatocytes<br />

proved that benzylpenicillin does not inhibit the<br />

membrane transport systems used by the toxin. An<br />

intracellular mechanism rather than interference with<br />

amanitin uptake appears responsible for the purported<br />

hepatoprotective effect. [279]<br />

Several theories have been advanced to explain the<br />

antitoxic action <strong>of</strong> benzylpenicillin. Floersheim’s<br />

hypothesis [280]<br />

that the drug could displace a-Ama<br />

from its binding site on serum protein is challenged by<br />

evidence that the toxic cyclopeptide does not bind to<br />

serum albumin. [266,281] Another hypothesis suggested<br />

that benzylpenicillin reduced or eliminated the GABAproducing<br />

intestinal flora involved in hepatic encephalopathy.<br />

[250,280] Although GABA appeared to be involved<br />

in experimental hepatic encephalopathy, the inhibitory<br />

neurotransmitter does not seem to play a role in human<br />

encephalopathy. [282]<br />

Other reports presented evidence <strong>of</strong> an anti-proliferative<br />

effect <strong>of</strong> b-lactam antibiotics on cultured<br />

eukaryotic cells including human sources and in vitro<br />

DNA replication systems. The intracellular target <strong>of</strong> blactams<br />

appears to be the replicative enzyme polymerase<br />

I. [283,284] Since the amatoxins, particularly a-Ama, are<br />

selective blockers <strong>of</strong> DNA-dependent RNA polymerase<br />

II, it is possible that the b-lactam antibiotics protect via<br />

their effects on eukaryotic DNA replication. [285]<br />

Although there is no formal pro<strong>of</strong>, in vitro experiments<br />

on chicken embryo hepatocytes and in vivo studies on<br />

mouse liver have shown that b-lactam antibiotics inhibit<br />

the toxic effect induced by a-Ama. [286]<br />

Unfortunately, benzylpenicillin commonly causes<br />

allergic drug reactions with an incidence <strong>of</strong><br />

1–10%. [126,287 – 289] The large amount <strong>of</strong> sodium ions<br />

administered with this antibiotic agent to amatoxinpoisoned<br />

patients may disrupt electrolyte balance. [290,291]<br />

Severe granulocytopenia has also been observed with<br />

high doses <strong>of</strong> benzylpenicillin. [292 – 294] Degradation<br />

products formed in vitro are <strong>of</strong>ten the causative agents<br />

<strong>of</strong> such adverse reactions rather than parent antibiotic.<br />

Use <strong>of</strong> freshly prepared single doses <strong>of</strong> benzylpenicillin<br />

prevents the majority <strong>of</strong> side effects. [295] However, given<br />

the bone narrow toxicity <strong>of</strong> b-lactams, these antibiotics<br />

[189,285] could affect all the hematopoietic cell<br />

lines. Lastly, massive benzylpenicillin therapy may<br />

MARCEL DEKKER, INC. 270 MADISON AVENUE NEW YORK, NY 10016<br />

©<strong>20</strong>02 Marcel Dekker, Inc. All rights reserved. This material may not be used or reproduced in any form without the express written permission <strong>of</strong> Marcel Dekker, Inc.<br />

evoke neurotoxic symptoms in patients with nervous<br />

system disease and renal insufficiency as well as induce<br />

convulsions when cerebral edema is imminent. [14,296]<br />

Although the biological mechanism <strong>of</strong> b-lactam<br />

antibiotics in the treatment <strong>of</strong> amatoxin poisoning is still<br />

unclear and high-dose benzylpenicillin can induce<br />

adverse reactions, the literature seems to support clinical<br />

benefits. Moroni et al. [297] reported 100% recovery for 33<br />

patients treated 1 or 2 days after ingestion <strong>of</strong> Amanita<br />

mushrooms with high doses <strong>of</strong> IV benzylpenicillin plus<br />

thioctic acid and steroids. Statistical <strong>analysis</strong> <strong>of</strong> a clinical<br />

study <strong>of</strong> <strong>20</strong>5 patients from Austria, France, Italy,<br />

Switzerland, and The Netherlands from 1971 to 1980<br />

found benzylpenicillin at 300,000–1,000,000 U/kg/day<br />

IV to be significantly associated with survival. [250,298]<br />

The suggested doses for benzylpenicillin are 40,000,000<br />

and 1,000,000 U/day in adults and children, respectively.<br />

[265] Benzylpenicillin is not approved by the US<br />

Food and Drug Administration (FDA) for treatment <strong>of</strong><br />

Amanita poisonings.<br />

In this <strong>20</strong>-<strong>year</strong> survey, benzylpenicillin was the most<br />

frequently used drug in the management <strong>of</strong> amatoxin<br />

poisoning, either as mono-chemotherapy in 164<br />

cases (10.1%, Table 3) or combined with other drugs<br />

as bi-chemotherapy (797 cases, 48.8%, Table 4), trichemotherapy<br />

(263 cases, 16.1%, Table 4), and polychemotherapy<br />

(187 cases, 11.5%, Table 6). In total,<br />

86.5% <strong>of</strong> Chem-group patients (1411/1632) receiving<br />

chemotherapy were treated with benzylpenicillin.<br />

Ceftazidime, a third generation cephalosporin, is<br />

several times more effective than benzylpenicillin by<br />

DNA replication systems testing in vitro. [284,286]<br />

According to the Neftel protocol, [196] ceftazidime is<br />

administered as 4.5 g IV every 2 hours. Despite the high<br />

drug concentrations in plasma, no renal and neurological<br />

side effects were reported. [197] Ceftazidime was the<br />

second most used b-lactam but was always combined<br />

with silybin (12 cases, Table 5).<br />

Silymarin Complex<br />

Enjalbert et al.<br />

Silymarin is a hepatoprotectant complex <strong>of</strong> natural<br />

substances isolated from seeds <strong>of</strong> Mediterranean milk<br />

thistle, Silybum marianum (L.) Gaertn. (Asteraceae ). [299]<br />

This flavonolignan group includes the three isomers<br />

silydianin, silychristin, and the major compound,<br />

silybin. [300,301] The beneficial effects <strong>of</strong> silymarin on<br />

death rate and survival time in intraperitoneal (IP)<br />

administered mice with a-Ama were reported by Hahn<br />

et al. [302] Silymarin efficacy depended on both the delay<br />

between intoxication and therapy, and the degree <strong>of</strong> liver

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!